Nicholas Fechtner⚡

ceo yuicy® - angel 25+ startups

📍 Germany🔄 Updated September 2026💼 4 investments📅 5 years investing🗓 Last invested Mar 2023
VC🌍 Germany
4
Total investments
3
Early stage
0
Mid stage
0
Late stage
5y
Years active

Portfolio

4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Mar 2023
Imagine a world without chocolate. Horrifying, right? But the supply of cocoa is endangered and chocolate is as bad as meat for our planet. We make future-proof chocolate using precision fermentation. Doing this, our chocolate is 10x more sustainable and 20% cheaper than conventional chocolate. In order to mimic the organoleptic properties of chocolate (tender, smoothly melting taste release) we are working on the flavor itself but also on replacing the cocoa butter. 55 Mio lbs of chocolate are consumed every day. By 2035 we will substitute a big chunk of it through our sustainable chocolate.
Investor
Feb 2022
Our vertical integrated ecosystem makes GCS the Gatekeeper in Germany * GCS Cultivation is building the largest German cultivation facility for medical cannabis to provide high quality strains, “Made‑in‑Germany”, to pharmacies that outperforms on freshness & consistency * Blütezeit is our own telemedicine platform providing legal and compliant access to medical cannabis by connecting doctors to patients. It serves as the patient-facing brand and primary patient gateway. * Cannaflow`s B2B software and marketplace empowers pharmacies to manage, distribute and connect cannabis via multiple channels, e.g. wholesale partners, telemedicine platforms and patients * Cannabiosan is our virtual wholesaler/GPO using an asset-light model to aggregate pharmacy demand and thus is key in the democratization process of pharmacies
Investor (EXIT)
Dec 2021
💊Medikamente, Pflege & Gesundheit zu dir geliefert. Deutschlandweit. Direkt aus der Apotheke.💙
Investor
May 2021
At PurposeMed, we envision a healthcare system without barriers to access high quality care. Our mission is to improve access to complex care for underserved communities by re-imagining how healthcare works by combining the best clinicians with smart design and technology. We’ve grown quickly in our first few years, and now our exceptional team serves thousands of patients each month across our multiple verticals.
Experience · 7 entries
All (7)
Investments (4)
Founder (2)
2023
Investor
Mar 2023
Imagine a world without chocolate. Horrifying, right? But the supply of cocoa is endangered and chocolate is as bad as meat for our planet. We make future-proof chocolate using precision fermentation. Doing this, our chocolate is 10x more sustainable and 20% cheaper than conventional chocolate. In order to mimic the organoleptic properties of chocolate (tender, smoothly melting taste release) we are working on the flavor itself but also on replacing the cocoa butter. 55 Mio lbs of chocolate are consumed every day. By 2035 we will substitute a big chunk of it through our sustainable chocolate.
2022
Investor
Feb 2022
Our vertical integrated ecosystem makes GCS the Gatekeeper in Germany * GCS Cultivation is building the largest German cultivation facility for medical cannabis to provide high quality strains, “Made‑in‑Germany”, to pharmacies that outperforms on freshness & consistency * Blütezeit is our own telemedicine platform providing legal and compliant access to medical cannabis by connecting doctors to patients. It serves as the patient-facing brand and primary patient gateway. * Cannaflow`s B2B software and marketplace empowers pharmacies to manage, distribute and connect cannabis via multiple channels, e.g. wholesale partners, telemedicine platforms and patients * Cannabiosan is our virtual wholesaler/GPO using an asset-light model to aggregate pharmacy demand and thus is key in the democratization process of pharmacies
2021
Investor (EXIT)
Dec 2021
💊Medikamente, Pflege & Gesundheit zu dir geliefert. Deutschlandweit. Direkt aus der Apotheke.💙
Limited Partner
Jul 2021
Fueling pioneers, turning bold science into planetary resilience. Nucleus is a first check deep-tech VC focused on Programmable Biology (Synbio & TechBio), Food Technology and Neo Industrials.
Investor
May 2021
At PurposeMed, we envision a healthcare system without barriers to access high quality care. Our mission is to improve access to complex care for underserved communities by re-imagining how healthcare works by combining the best clinicians with smart design and technology. We’ve grown quickly in our first few years, and now our exceptional team serves thousands of patients each month across our multiple verticals.
Show all 7 entries ↓
Investment activity
2021–2023 · 4 investments
202122022120231
Recent (last 2 years)Earlier